Shining on G-economy Tuesday

Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

It is a G-economy day with the government bonds down, credit spreads tightening, oil up and the gold-silver ratio falling. That should give today's morning report stock featured on INK Ultra Money a relative boost against its gold-focused peers. Canadian Insider Club Ultra members have full access. If you are not an Ultra member, join us or upgrade today.

1. The silver lining for Yamana Gold - INK Research

Yamana Gold (YRI) has been one of the top three performers in the INK Canadian Insider Index so far this year. The company's exposure to silver has served as a bit of headwind, but could that situation change?


Guidance updated


2. Second wave worries - Real Vision


Dr. Dena Grayson speaks to Pedro Da Costa about the ongoing efforts of medical professionals to save lives and stop the COVID-19 pandemic in its tracks. She evaluates the promising new drug Remdesivir and discusses her work on similar drugs such as Galidesivir and Favipiravir. She shares her thoughts on herd immunity, the possibility of a vaccine, as well as the different efforts of governments worldwide to contain the pandemic. Filmed on April 30, 2020.

The next wave is likely to be worse

Don't forget to watch the Real Vision Daily Briefing. Watch the May 4th edition>>

affiliate tracking url | Nike Dunk Low Coast UNCL - Grailify

Join the discussion in INK Chat!